Study identification

PURI

https://redirect.ema.europa.eu/resource/1000000462

EU PAS number

EUPAS1000000462

Study ID

1000000462

Official title and acronym

Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: cardiovascular and respiratory outcomes

DARWIN EU® study

No

Study countries

Sweden

Study description

Objective: To assess cardiovascular effectiveness and respiratory safety of beta-blocker treatment in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease

Study status

Ongoing
Research institutions and networks

Institutions

Karolinska Institutet
Sweden
First published:
01/02/2024
InstitutionEducational Institution

Contact details

Benedikt N. Beer

Primary lead investigator
ORCID number:
0000-0003-4315-2533
Study timelines

Date when funding contract was signed

Actual:

Study start date

Actual:

Data analysis start date

Actual:

Date of final study report

Planned:
Sources of funding
EU institutional research programme
Other public funding (e.g. hospital or university)

More details on funding

This work is supported by the Horizon Europe programme (project number 101095479 - More-EUROPA), and the Swedish Heart and Lung Foundation (project number 20220680) to Dr. Gianluigi Savarese´s institution. Dr. Benedikt Beer is supported by a grant of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; grant number 535014557).
Study protocol
Initial protocol

BB in COPD_HARPER_2025-01-27.pdf

English (803.39 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable